Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis

• Larisa Broglie,
• Lauren Pommert,
• Sridhar Rao,
• Monica Thakar,
• Rachel Phelan,
• David Margolis,
• Julie Talano

Affiliations

Larisa Broglie

Division of Hematology, Oncology, and Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;; Children's Hospital of Wisconsin, Milwaukee, WI;

Lauren Pommert

Children's Hospital of Wisconsin, Milwaukee, WI;; Division of Hematology, Oncology, and Blood and Marrow Transplant, Department of Pediatrics, Children's Hospital of Wisconsin, Milwaukee, WI; and

Sridhar Rao

Blood Research Institute, Medical College of Wisconsin, Milwaukee, WI

Monica Thakar

Division of Hematology, Oncology, and Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;; Children's Hospital of Wisconsin, Milwaukee, WI;

Rachel Phelan

Division of Hematology, Oncology, and Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;; Children's Hospital of Wisconsin, Milwaukee, WI;

David Margolis

Division of Hematology, Oncology, and Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;; Children's Hospital of Wisconsin, Milwaukee, WI;

Julie Talano

Division of Hematology, Oncology, and Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI;; Children's Hospital of Wisconsin, Milwaukee, WI;; Julie Talano, Department of Pediatrics, Division of Hematology, Oncology, Blood and Marrow Transplant, Medical College of Wisconsin, 8701 Watertown Plank Rd, MFRC 3018, Milwaukee, WI 53226;